Diagnostics (HEV)

Performance of Commercial Assay for Hepatitis E Antibody of Concern

Published in Hepatitis Weekly, February 7th, 2000

A comparison study of assays for hepatitis E virus (HEV) antibody detection found a widely used commercial test was less sensitive and produced more inconsistent results than assays developed by the US National Institutes of Health and Japan's National Institutes of Infectious Diseases.

Researcher M. Abdel-Hamid and colleagues at the Minia University School of Medicine, the US and Japanese government agencies, and elsewhere evaluated the assays using samples from a southern Egypt community and from a Nile Delta region community, they said. They reported their findings at the 48th Annual Meeting of the American Society of Tropical Medicine and Hygiene, held November 28...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2000-02-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry